Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients

Show other versions (1)

<p>Traditionally, the concern of fatal complication is a major obstacle to transfer patients with unfavorable course of Hodgkin’s lymphoma to<br />national transplantation centers. Early mortality after high-dose chemotherapy with autologous hematopoietic stem cell transplantation<br...

Full description

Bibliographic Details
Main Authors: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasyev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, E. E. Karamanesht, N. G. Tyurina, O. A. Pavlova, A. G. Rumyantsev, A. D. Kaprin
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkogematologiâ
Subjects:
Hodgkin lymphoma
high-dose chemotherapy
hematopoietic stem cell transplantation
toxicity
Online Access:http://oncohematology.abvpress.ru/index.php/ongm/article/view/24

Similar Items

Similar Items